Carter Denise P. has filed 12 insider transactions across 1 company since October 2023.
Most recent transaction: a grant/award of 318750 shares of Quoin Pharmaceuticals, Ltd. ($QNRX) on February 04, 2026.
Activity breakdown: 7 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Quoin Pharmaceuticals, Ltd. | $QNRX | Carter Denise P. | Chief Operating Officer | A | Share Option (Right to Buy) | 318750 | $0.00 | 318,750.0000 | 1,584,905,594 | 9999.99% | 0.02% |
| May 29, 2025 | Quoin Pharmaceuticals, Ltd. | $QNRX | Carter Denise P. | Chief Operating Officer | A | Share Option (Right to Buy) | 42857 | $0.00 | 42,857.0000 | 1,584,905,594 | 9999.99% | 0.00% |
| May 29, 2025 | Quoin Pharmaceuticals, Ltd. | $QNRX | Carter Denise P. | Chief Operating Officer | A | Share Option (Right to Buy) | 42039 | $0.00 | 42,039.0000 | 1,584,905,594 | 9999.99% | 0.00% |
| Dec. 23, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Carter Denise P. | Chief Operating Officer | P | Ordinary Shares | 555556 | $0.45 | 602,648.0000 | 1,584,905,594 | 1179.73% | 0.04% |
| Dec. 23, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Carter Denise P. | Chief Operating Officer | P | Series F Warrants (right to buy) | 555556 | $0.00 | 555,556.0000 | 1,584,905,594 | 9999.99% | 0.04% |
| Dec. 23, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Carter Denise P. | Chief Operating Officer | P | Series G Warrants (right to buy) | 555556 | $0.00 | 555,556.0000 | 1,584,905,594 | 9999.99% | 0.04% |
| Dec. 9, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Carter Denise P. | Chief Operating Officer | A | Share Option (Right to Buy) | 536609 | $0.00 | 536,609.0000 | 1,584,905,594 | 9999.99% | 0.03% |
| Sept. 3, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Carter Denise P. | Chief Operating Officer | P | Ordinary Shares | 4100 | $0.66 | 15,279.0000 | 1,584,905,594 | 36.68% | 0.00% |
| Sept. 4, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Carter Denise P. | Chief Operating Officer | P | Ordinary Shares | 8825 | $0.75 | 24,104.0000 | 1,584,905,594 | 57.76% | 0.00% |
| Sept. 4, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Carter Denise P. | Chief Operating Officer | P | Ordinary Shares | 22988 | $0.80 | 47,092.0000 | 1,584,905,594 | 95.37% | 0.00% |
| Sept. 3, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Carter Denise P. | Chief Operating Officer | P | Ordinary Shares | 1822 | $0.63 | 11,179.0000 | 1,584,905,594 | 19.47% | 0.00% |
| Oct. 26, 2023 | Quoin Pharmaceuticals, Ltd. | $QNRX | Carter Denise P. | Chief Operating Officer | A | Share Option (Right to Buy) | 80966 | $0.00 | 80,966.0000 | 1,584,905,594 | 9999.99% | 0.01% |